Myeloma and marrow adiposity: Unanswered questions and future directions by Morris, EV, Edwards, CM

Morphogens and growth factor signalling in the myeloma bone-lining niche by Morris, EV, Edwards, CM

The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo by Gámez, B, Morris, EV, Olechnowicz, SWZ, Webb, S, Edwards, JR, Sowman, A, Turner, CJ, Edwards, CM

Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival by Whitburn, J, Rao, SR, Morris, EV, Tabata, S, Hirayama, A, Soga, T, Edwards, JR, Kaya, Z, Palmer, C, Hamdy, FC, Edwards, CM

Myeloma cells down-regulate adiponectin in bone marrow adipocytes via TNF-alpha by Morris, EV, Suchacki, KJ, Hocking, J, Cartwright, R, Sowman, A, Gamez, B, Lea, R, Drake, MT, Cawthorn, WP, Edwards, CM

Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease by Leng, H, Zhang, H, Li, L, Zhang, S, Wang, Y, Chavda, SJ, Galas-Filipowicz, D, Lou, H, Ersek, A, Morris, EV, Sezgin, E, Lee, Y-H, Li, Y, Lechuga-Vieco, AV, Tian, M, Mi, J-Q, Yong, K, Zhong, Q, Edwards, CM, Simon, AK, Horwood, NJ